Clinical Practice Guidelines Committee


Chair: Dr Andy Lewington,

The Clinical Practice Guidelines Committee was established by the UK Renal Association (RA) to prepare guidelines for the management of patients with renal disease and help identify the data to be collected by the Renal Registry.

The RA has produced guidance on best practice in the management of patients with kidney disease since 1995. The RA Clinical Practice Guidelines are not funded by any external organisation, commercial company or charity.

In 2013 it was agreed that for appropriate topics The Renal Association would produce joint adult and paediatric guidelines with the British Association for Paediatric Nephrology .

NICE Accreditation

The National Institute for Health and Care Excellence (NICE) has accredited the process used by The Renal Association to produce its Clinical Practice Guidelines. Accreditation is valid for 5 years from 9 November 2010.

Accreditation helps health and social care professionals identify the most robustly produced guidance available, enabling them to deliver high quality care.

More information on accreditation can be viewed at


Clinical Practice Guidelines Commitee 2013

Andy Lewington (Chair)    Shona Methven 
 Neil Duncan   Clara Day 
 Vicky Briggs   Graham Woodrow 
 Andrew Mooney   Ed Sharples 
 Simon Steddon   Marlies Ostermann 
 Martin Wilkie   Graham Warwick 
 David Goldsmith   Suren Kanagasundaram 
 Ashraf Mikhail   Richard Baker 
 Mark MacGregor   Mark Wright 
 Paul Harden   Mick Kumwenda 
 Cormac Breen   Sandip Mitra 
 Mike Robson  

Current Edition of the Clinical Practice Guidelines

Module Date Review due
Acute Kidney Injury - Dr Andrew Lewington & DrSuren Kanagasundaram 08/03/11 2015
Anaemia in CKD - Dr Ashraf Mikhail, Dr Rajesh Shrivastava & Dr Donald Richardson 15/11/10 2015 
Assessment of the Potential Kidney Transplant Recipient - Dr Chris Dudley & Dr Paul Harden 12/01/11  2015 
Blood-borne viruses - Dr Colin Geddes, Dr Elizabeth Lindley & Dr Neill Duncan 14/07/09 2014
Cardiovascular disease in CKD - Dr Stephen Holt & Dr David Goldsmith 06/08/10  2015 
CKD-Mineral and Bone Disorders (CKD-MBD) - Dr Simon Steddon & Dr Edward Sharples
01/03/15 2020
Detection, Monitoring and Care of Patients with CKD - Dr Mark S. MacGregor & Dr Maarten W. Taal 28/02/11 2015
Haemodialysis - Dr Robert Mactier, Dr Nic Hoenich & Dr Cormac Breen 01/12/09 2012 
Nutrition in CKD - Dr Mark Wright & Dr Colin Jones 25/06/10  2015 
Peritoneal access - Dr Martin Wilkie, Dr Sarah Jenkins & Dr Badi Shrestha 22/09/09  2014 
Peritoneal dialysis - Dr Graham Woodrow & Prof Simon Davies 30/07/10 2015 
Planning, initiation & withdrawal of Renal Replacement Therapy - Dr Graham Warwick & Dr Andrew Mooney 01/02/14 2019 
Post-operative Care of the Kidney Transplant Recipient - Dr R Baker, Professor A Jardine & Dr Peter Andrews 05/02/11 2015 
Vascular Access For Haemodialysis - Dr Mick Kumwenda, Dr Sandip Mitra & Dr Claire Reid 31/3/2015 2020


Recent Activity

Guideline for the perioperative management of people with inherited salt-wasting alkaloses (Gitelman’s syndrome and Bartter’s syndrome) undergoing non-urgent surgical procedures

Hugh Gallagher and Charlie Tomson from the Rare Disease Working Group on Salt-Wasting Alkaloses (SWA) have been working with Dr Jasmeet Soar from the Royal College of Anaesthetists to produce a guideline on the peri-operative management of people with SWA.   The guideline covers the perioperative care of adults with an existing formal diagnosis of an inherited SWA, such as Bartter’s syndrome and Gitelman’s syndrome,  who are having elective or expedited surgery.  It includes recommendations on pre-operative assessment, minimum acceptable levels of potassium and magnesium, and intra- and post- procedural monitoring.  This joint guideline has been endorsed by the Renal Association and the Royal College of Anaesthetists.  The aim is to improve the current inconsistent approach whereby patients with SWA may be denied surgery on the basis of chronic and stable metabolic abnormalities.

Please click here to access the guideline via the list of available joint guidelines. 

Guidelines to Review - Clinical Practice Guideline Vascular Access For Haemodialysis In Adults

 Many studies have shown the superiority of AVF compared to the other forms of haemodialysis. AVF have better patency rates, access survival, lower number of interventions during the entire life span of access type, lower rates of access related sepsis and the overall morbidity and mortality is much lower compared to AVG and central venous haemodialysis catheters. In addition, both hospitalisation frequency and costs are the lowest with AVF compared to other forms of vascular access and yet there is wide variation in the UK in the provision of AVF as definite vascular access for people with end stage kidney disease on haemodialysis. Achieving good quality access remains a challenge, requiring a coordinated and multidisciplinary approach in assessing patients in order that access is created in advance of the need for dialysis. This guideline updates the section on vascular access in the haemodialysis module of the 5th edition of the RA guidelines published on-line at in 2011 and it is recommended that cross reference is made to the 6th edition of Clinical Guidelines Planning, Initiating and Withdrawal of Renal Replacement Therapy UK Renal Association published recently. The objective of the recommendations is to provide an update of the current practice in the management of vascular access in order to optimise outcomes. The guideline recommendations are based on literature review from relevant publications in journals cited on MEDLINE, PubMed and UpToDate up to October 2014.

Please click here to access the guideline for review.

© Renal Association 2013
All rights reserved. Use of this website constitutes acceptance of the Privacy Policy and Terms and Conditions.

Design and Development  by MCI
Contact us
The Renal Association
Durford Mill
GU31 5AZ
Tel: 01730 715 215
Fax: 01730 715 291